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Background: Cancer stem cells are thought to be responsible for the initiation and progression of cancers. In
non-small cell lung cancers (NSCLCs), Hoechst 33342 dye effluxing side population (SP) cells are shown to have
stem cell like properties. The oncogenic capacity of cancer stem-like cells is in part due to their ability to self-renew;
however the mechanistic correlation between oncogenic pathways and self-renewal of cancer stem-like cells has
remained elusive. Here we characterized the SP cells at the molecular level and evaluated its ability to generate
tumors at the orthotopic site in the lung microenvironment. Further, we investigated if the self-renewal of SP cells
is dependent on EGFR mediated signaling.
Results: SP cells were detected and isolated from multiple NSCLC cell lines (H1650, H1975, A549), as well as primary
human tumor explants grown in nude mice. SP cells demonstrated stem-like properties including ability to
self-renew and grow as spheres; they were able to generate primary and metastatic tumors upon orthotopic
implantation into the lung of SCID mice. In vitro study revealed elevated expression of stem cell associated markers
like Oct4, Sox2 and Nanog as well as demonstrated intrinsic epithelial to mesenchymal transition features in SP
cells. Further, we show that abrogation of EGFR, Src and Akt signaling through pharmacological or genetic
inhibitors suppresses the self-renewal growth and expansion of SP-cells and resulted in specific downregulation of
Sox2 protein expression. siRNA mediated depletion of Sox2 significantly blocked the SP phenotype as well as its
self-renewal capacity; whereas other transcription factors like Oct4 and Nanog played a relatively lesser role in
regulating self-renewal. Interestingly, Sox2 was elevated in metastatic foci of human NSCLC samples.
Conclusions: Our findings suggest that Sox2 is a novel target of EGFR-Src-Akt signaling in NSCLCs that modulates
self-renewal and expansion of stem-like cells from NSCLC. Therefore, the outcome of the EGFR-Src-Akt targeted
therapy may rely upon the expression and function of Sox2 within the NSCLC-CSCs.
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Despite significant therapeutic advances, lung cancer
causes the maximum number of cancer related deaths
worldwide [1]. In the United States, ~85% of the patients
diagnosed with NSCLCs, die within five years [2-4], thus,
highlight a need for better understanding of the cellular
and molecular events underlying the genesis of this dis-
ease. Cancer stem cell model has emerged as a viable* Correspondence: Srikumar.Chellappan@moffitt.org
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reproduction in any medium, provided the orexplanation for the initiation and progression of the ag-
gressive cancers like NSCLCs.
Cancer stem cell model suggests that cancer stem-like
cells (CSCs) are a subpopulation of cells within the
tumor that have the deregulated properties of normal
stem cells with sustained self-renewal, and can generate
secondary tumors that recapitulate the heterogeneity
and diversity of original tumor [5-8]. CSCs are consid-
ered to be responsible for tumor initiation, propagation,
recurrence and resistance to therapy [9,10]. Hoechst
33342 dye excluding cells, termed side-population (SP)
cells, have been described as CSCs in a variety of tumortd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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shown to display increased tumorigenicity when trans-
planted into immunocompromised mice [12,13] as com-
pared to major population (MP) cells. SP phenotype is
dependent on the differential ability of cells to efflux the
Hoechst 33342 dye via the ATP-binding cassette (ABC)
family of transporter protein, mainly ABCG2 (breast
cancer resistance protein, BRCP1) which is specifically
expressed on the cell membrane of stem cell populations
[14]. Earlier studies have demonstrated the existence of
SP cells in various established human NSCLC cell lines
[11] but their ability to generate tumors in lung micro-
environment as well as the signaling pathways governing
their stem-like properties remain to be elucidated.
The transcription factors Oct4, Sox2 and Nanog have
been identified as core regulators that maintain the self-
renewal of embryonic stem cells [15]. These factors are
overexpressed in various cancers and are associated with
malignant progression and poor prognosis including
NSCLCs [16,17], suggesting that the core regulators that
govern normal stem cell self-renewal may also maintain
the stem-like properties of CSCs in cancers. However,
the influence of NSCLC specific oncogenic pathways on
the expression of these factors remains relatively un-
known. Alterations in EGFR-gene like copy number
gains and/or mutant allele-specific amplifications are
associated with NSCLC pathogenesis. In addition, activa-
tion of EGFR signaling increases the self-renewal cap-
acity of neural precursor cells and brain tumor stem
cells [18-20]. In this study, we provide biochemical and
biological evidence that SP cells isolated from estab-
lished human NSCLC cell lines and tumors are highly
enriched in NSCLC-CSCs and EGFR-Src-Akt signaling
axis contributes significantly to the self-renewal of SP
cells. Interestingly, Sox2 transcription factor is the pre-
dominant downstream target of EGFR signaling in these
cells and plays a major role in self-renewal growth and
expansion of SP cells, independent of Oct4 and Nanog.
Results
SP cells are enriched with tumorigenic cells and produce
highly invasive tumors
In an attempt to identify NSCLC stem-like cells, SP ana-
lysis was conducted on four primary human NSCLC
explants grown in athymic nude mice. SP cells appeared
as a well separated population as described previously
[21]. As shown in Figure 1A, a specific inhibitor of
ABCG2 [22], Fumitremorgin C (FTC) could block the ap-
pearance of SP phenotype. All the four tumor samples dis-
played the presence of SP cells with varying frequency
ranging from 0.6-3%, and could be significantly blocked by
FTC (Figure 1B).
Self-renewing normal or cancer-stem-like cells can be
expanded as non-adherent spheres when cultured at lowdensity in serum free, stem cell selective medium; differ-
entiated cells do not grow or form spheres under these
conditions [6,23,24]. The self-renewal property of SP
cells was examined by performing sphere formation
assay on sorted SP and MP cells isolated from human
tumor xenografts. While sorted SP cells were able to
grow as spheres, MP cells had markedly less capacity to
grow under identical conditions (Figure 1C).
Attempts were then made to assess the presence of
SP cells in human NSCLC cell lines. As shown in later
sections, A549 (K-Ras mutant; wild type EGFR amplifi-
cation), H1650 (EGFR mutant; Exon 20 deletion:
delE746-A750) and H1975 (EGFR mutant; L858R and
T790M mutations), contained SP-cells with varying fre-
quency. Appearance of SP cells was completely blocked
by FTC. Sorted SP cells were able to grow as spheres
whereas MP cells showed markedly reduced capability
(Figure 1D) suggesting that NSCLC-SP cells are
enriched with CSCs.
The stem cell like property of NSCLC-SP cells was
verified by evaluating its ability to form tumors in the
lung microenvironment. Sorted SP and MP cells from
A549 cells stably expressing the luciferase gene were
orthotopically implanted into the left lung of SCID mice
and tumor growth was monitored for 12 weeks. As
shown in Figure 1E, SP cells generated primary tumors
in the lung more efficiently than MP cells. At the end of
the experiment, lungs, liver, kidney and brain were
excised from each mouse and ex-vivo images were
examined for the presence of metastasized luciferase
positive cells. Mice injected with SP cells demonstrated
substantial tumor burden throughout the lungs and
showed luminescent metastatic loci in liver, kidney
(adrenals) and brain (Figure 1F). In contrast, MP cells
formed only one luminescent focus in the lung of one
mouse (out of five) injected with 50 000 MP cells and
there was no metastasis (Figure 1F). These results were
confirmed by H&E staining; further, tumors formed
within the lung from SP cells, recapitulated the histo-
pathology of adenocarcinoma as confirmed by positive
staining with pan-keratin antibody as well as mucicar-
mine dye (Figure 1G). These data suggested that SP cells
are enriched with tumorigenic cells and can develop
metastatic tumors in vivo.
SP cells exhibit molecular markers of stem-like cells
Recent reports suggest that epithelial cells acquire can-
cer stem cell properties upon induction of epithelial to
mesenchymal transition (EMT) [25]. To evaluate
whether SP cells show features of EMT, SP and MP cells
from A549, H1650 and H1975 were examined for the
levels of EMT markers like E-cadherin, Vimentin and
Fibronectin. As shown in Figure 2A, ABCG2 expression
was significantly higher in the SP fraction in all the three
Figure 1 SP cells exhibit stem-like properties. (A) FACS analysis on single cell suspension of human NSCLC xenograft stained with Hoechst
33342 dye showing SP cells. Fumitremorgin C (FTC) inhibited the efflux of the dye and caused the disappearance of SP cells. (B) SP cell frequency
in presence or absence of FTC in four different human tumor xenografts. (C) Sphere formation assay on SP or MP cells grown in stem cell
selective media for 10 days. The pictures of representative spheres are presented. The bar diagram show the average (±SD) number of spheres
formed from 2000 cells. (D) SP or MP cells from H1650 and H1975 cell lines were plated in serum free medium supplemented with EGF and
bFGF for 10 days under self-renewal assay conditions. The pictures of representative spheres are depicted (E) Indicated number of SP and MP
cells from A549-Luc cell line were implanted into the right lung tissue of SCID mice. The tumor incidence and metastasis was monitored for
12 weeks by bioluminescence imaging. (F) Ex-vivo images of the lung, liver, kidney/adrenals and brain captured at the end of experiment.
Metastasis was prevalent in SP cells implanted mice. (G) H&E, pan-keratin (brown staining) and mucicarmine (pink staining, indicated by arrow
head) staining of whole lungs from mice implanted with SP or MP cells.
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SP cells as compared to MP cells, however, it was un-
detectable in A549 and unchanged in H1975 cells. Fibro-
nectin was detected at higher levels in A549 and H1975-
SP cells, but undetectable in H1650 cells. Vimentin levelwas higher in A549-SP cells, but low in H1975 and
H1650 SP cells. Although the levels vary in a cell type
dependent manner, these results suggest that, SP cells
express proteins indicative of EMT without any external
stimuli to the cells (Figure 2A). The molecular basis for
Figure 2 SP cells express stem cell-like markers. (A) Western blot analysis on SP and MP cells from A549, H1650 and H1975 cell lines for the
indicated proteins. β-Actin was used as the loading control. (B, C, D) SP and MP cells were analyzed by real time qRT-PCR method for the
expression of Twist, Slug and Snail genes. Average (±SD) fold change between MP and SP cells were plotted. (E, F, G) SP and MP cells were
analyzed by real time qPCR method for the expression of ABCG2, Oct4, Sox2 and Nanog genes. Average (±SD) fold change between MP and SP
cells were plotted. (H) The spheres formed in self-renewal assays of H1650 SP cells were stained for the expression of ABCG2, Oct4, Sox2 and
Nanog. Confocal image of one of the z-stacks for a sphere is presented. DAPI was used to stain the nucleus.
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examined. Transcription factors like Twist, Slug and
Snail have been demonstrated to be capable of coordin-
ating the EMT program during embryonic development
and in cancers [26,27]. Therefore, we next assessed the
expression of these transcription factors in SP and MP
cells. Real-time PCR analysis revealed that Twist, Slug
and Snail transcription factors are expressed at higher
levels in SP cells in all the three NSCLC cell lines
(Figure 2B, C, D).The expression of Oct4, Sox2 and Nanog transcrip-
tion factors was next examined in SP cells. Real-time
PCR analysis showed elevated levels of ABCG2, Oct4,
Sox2, and Nanog in the SP fraction in all the three
cell lines. (Figure 2E, F, G). Further, SP cells from
H1650 cells growing as spheres showed expression of
ABCG2, Oct4, Sox2 and Nanog proteins by fluores-
cence microscopy (Figure 2H), indicating the undiffer-
entiated growth of self-renewing SP cells within the
spheres.
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and SP phenotype
Experiments were conducted to explore the molecular
mechanisms involved in the self-renewal of SP cells. Since
aberrant EGFR signaling is implicated with the initiation
and progression of lung cancer, we first assessed SP fre-
quency and expression of ABCG2 in the presence of an
antagonistic antibody against EGFR. Cells were mixed
with 10 μg/ml anti-EGFR antibody or an isotype control
and plated in 2% FBS containing media for 5 days. Block-
ing EGF-receptors resulted in a significant decrease in SP
frequency in both A549 and H1650 cells (Figure 3A, B),
along with decreased EGFR phosphorylation as well as
ABCG2 expression in both the cell lines (Figure 3C). Con-
firming these results, depletion of EGFR expression by a
siRNA resulted in decreased SP frequency and ABCG2 ex-
pression in A549, H1650 and H1975 cells (Figure 3D, E).
To further evaluate whether EGFR signaling contribu-
ted to the self-renewal property of H1650 SP cells, sphere
formation assay was conducted in the presence or ab-
sence of EGFR inhibitors Gefitinib or Erlotinib. As shown
in Figure 3F, inhibition of EGFR-kinase activity by
500 nM of Gefitinib or Erlotinib, demonstrated a 5–7
fold (p< 0.001) decrease in the number of spheres; further
the size of the spheres was also significantly reduced.
A secondary point mutation in exon 20 of EGFR
(T790M) is associated with acquired resistance to gefiti-
nib or Erlotinib, but this can be overcome by the irre-
versible EGFR-tyrosine kinase inhibitor BIBW2992
(BIBW). We tested the effect of 500 nM of gefitinib and
200 nM of BIBW on EGFR phosphorylation and self-
renewal growth of SP cells from H1975 cell line, which
harbors gefitinib-resistant-T790M mutation along with
Gefitinib responsive-L858R mutation in exon 21. West-
ern blot analysis showed that tyrosine phosphorylation
of EGFR was insensitive to 500 nM concentration of
gefitinib, whereas significant downregulation occurred
after treatment with 200 nM of BIBW in H1975 cells
(Additional file 1: Figure S1). Consistent with this, BIBW
could significantly inhibit the self-renewal of SP cells
from H1975 cells (Figure 3G).
Adherent cultures of SP cells maintain stem-like
properties
To conduct further molecular studies on SP cells, we
attempted to establish adherent cell cultures of isolated
SP cells from A549, H1975 and H1650 cell lines, as sug-
gested for glioma stem cells [28]. Isolated SP cells were
plated on uncoated or Poly-D Lysine + Laminin coated
culture plates in serum free, stem cell media. While
A549-SP and H1975-SP cells detached from the surface,
H1650-SP cells grew as an adherent culture. As shown
in Figure 3A, H1650-SP cells cultured on uncoated sur-
face failed to maintain SP phenotype with highfrequency (Figure 4A, (i)), but 80% of the cells main-
tained as SP cells even after 5 passages when plated on
PDL + laminin coated surface (Figure 4A, (ii); H1650-
SPAdh cells). H1650-SPAdh cells cultured back in 5%
FBS containing medium for 10 days could recapitulate
the proportion of SP and MP cells found in parental
H1650 cells (Figure 4A, (iii)), with a concomitant reduc-
tion in expression of ABCG2 (Figure 4B), as well as Oct4,
Sox2 and Nanog mRNA as seen by R-PCR (Figure 4C).
Cell cycle analysis showed that H1650-SPAdh cells were
slow cycling compared to parental cells (Figure 4D), hav-
ing approximately 20% higher number of cells in G0/G1
phase; but upon serum-induced differentiation, H1650-
SPAdh cells acquired cell-cycle phase distribution com-
parable to H1650-parental cells (Figure 4D).
Treatment of H1650-SPAdh cells with 200 nM BIBW
significantly suppressed the number as well as the size of
spheres (Figure 4E); at the same time, treatment with
30 μM cisplatin did not affect the number or the size of
the spheres formed by H1650-SP cells, suggesting
enhanced chemoresistance of these cells. Further, the
sphere-formation ability of SP was not altered by the
ABCG2 inhibitor, FTC, suggesting that self-renewal of
SP cells was independent of ABCG2 activity (Figure 4E).
Inhibition of EGFR-Src-Akt signaling downregulates Sox2
expression
Experiments were conducted to examine the down-
stream signaling events from EGFR that modulates self-
renewal of SP cells and whether these pathways impinge
transcription factors associated with stemness. Role of c-
Src in the process was first examined since Src is altered
in NSCLC [29,30]. H1650-SPAdh cells were treated with
EGFR or Src TKIs and the levels of Oct4 and Sox2 was
assessed by western blotting (Figure 5A). EGFR inhib-
ition by 500 nM gefitinib or 200 nM BIBW as well as in-
hibition of Src activity by 200 nM dasatinib or 1 μM
PP2 markedly reduced Sox2 expression; Oct4 level was
not affected (Figure 5A). These results were verified by
immunoflorescence experiments. Similar to Oct4, there
was no significant difference in Nanog expression; how-
ever, the number Sox2 positive cells were significantly
decreased in response to the treatment of EGFR- and
Src-TKIs (Additional file 1: Figure S2).
Inhibition of EGFR as well as Src signaling resulted in
decreased phosphorylation of EGFR, Src, ERK and Akt
(Figure 5A). Contribution of ERK and Akt pathways to
EGFR mediated induction of Sox2 was next examined
in H1650SPAdh cells. Phosphorylation of ERK was
suppressed by MEK inhibitor PD98059 and AKT-
phosphorylation was suppressed by the PI3-kinase in-
hibitor, LY294002. However, PI3-Kinase inhibited
H1650SPAdh cells also resulted in slight inhibition in
ERK phosphorylation (Figure 5B). A similar observation
Figure 3 Inhibition of EGFR suppresses SP frequency and self-renewal. (A) H1650 and A549 cells revealed a significant decrease in SP
frequency after treatment with 10 μg/ml EGFR-neutralizing antibodies for 5 days. (B) Frequency of SP cells in control antibody (1) and EGFR-
neutralizing antibodies (2) treated cells. (C) Western blot analysis for ABCG2 and phospho-EGFR after EGFR-neutralizing antibody treatment. (D) SP
frequency in NSCLC cells transfected with siRNA against EGFR or a control siRNA. (E) Expression of ABCG2 and EGFR in antibody treated cells.
(F and G) SP cells were sorted and plated for self-renewal assay in the presence or absence of indicated drugs. Average number of spheres
generated per well from 1000 cells is plotted (mean ± SD). Phase contrast microscopy images of the spheres in presence or absence of drugs are
presented. * represent the p value of <0.05; ** represent the p value of <0.01; *** represent the p value of <0.001.
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Figure 4 Establishment and characterization of H1650-SPAdh cells. (A) SP cells from H1650 cell line was plated on normal tissue culture
plate (i) or poly-D-lysine-laminin (PDL-Laminin) coated surface (ii) in serum free medium containing N2-supplement, EGF and bFGF. H1650-SPAdh
cells growing in self-renewing condition was cultured in serum for 5 days to induce differentiation, and reanalyzed for SP frequency (iii). (B)
Serum induces differentiation of SPAdh cells as seen by ABCG2 expression and (C) real time qPCR analysis for stem cell markers, ABCG2, Oct4,
Sox2, Nanog. (D) Cell cycle analysis for parental-H1650 or H1650-SPAdh and serum differentiated H1650-SPAdh cells grown on PDL-Laminin
coated surface. Histograms were plotted using ModFit program. (E) The average number of spheres generated from 1000 H1650-SPAdh cells is
plotted (mean ± SD). Phase contrast microscopy images of the spheres in presence or absence of indicated drugs.
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Figure 5 Inhibition of EGFR signaling downregulates Sox2 expression (A) H1650-SPAdh cells were treated with EGFR or Src inhibitors
for 4 days and western blot analysis was performed for the indicated proteins. (B) H1650-SPAdh cells were treated with MEK or PI3K
inhibitor for 4 days and levels of Sox2 and activation of Akt or ERK was evaluated by western blot. (C) A549 and H1975 cells were treated with
MEK or PI3K inhibitor for 5 days and the frequency of SP cells were examined by SP analysis. Data represents the fold change in mean (± SD) of
SP frequency. (D) ABCG2 expression upon inhibitor treatment as detected by western blotting. (E) SP cell frequency in NSCLC cell lines
transfected with specific siRNAs against Src or AKT. (F) ABCG2 expression in siRNA transfected cells as detected by western blotting. (G and H) SP
cells were sorted and plated for self-renewal assay in the presence or absence of indicated drugs. Average number of spheres generated from
1000 cells is plotted (mean± SD). Phase contrast microscopy images of the spheres in presence or absence of drugs are presented. * represent
the p value of <0.05; ** represent the p value of <0.01; *** represent the p value of <0.001.
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naling was demonstrated to regulate the ERK phosphor-
ylation in T-cell-receptor (TCR) signaling [31] and
PDGFR mediated signaling [32]. However, as shown in
Figure 5B, inhibition of MEK activity did not affect the
levels of Sox2 while the PI3-kinase inhibition, markedly
reduced its levels with corresponding reduction in SP fre-
quency (Figure 5C) and ABCG2 expression (Figure 5D).
These results were confirmed using siRNAs to Src and
Akt. As shown in Figure 5E, SP frequency was signifi-
cantly downregulated in both Akt and Src siRNA trans-
fected A549, H1650 and H1975 cells as compared to the
control siRNA transfected cells, with a corresponding re-
duction in ABCG2 expression (Figure 5F). Similar inhibi-
tory effects were observed upon silencing of two other
Src family members, Fyn and Yes (data not shown).
To determine whether Src or Akt signaling facilitates
self-renewal of SP cells, sphere formation assay was con-
ducted on SP cells in presence or absence of Src inhibi-
tors Dasatinib or PP2, MEK inhibitor PD98059 as well
as Akt inhibitor LY294002. As shown in Figures 5G andFigure 6 Sox2 is necessary for maintaining the self-renewal of SP cell
siRNA, or siRNA against EGFR, Src, or Sox2 and western blot analysis was pe
cells were plated for self-renewal assay and analyzed after 5 days of plating
plotted (mean ± SD). (C) NSCLC cell lines were transfected with control or
SP-frequency (± SD) is plotted. (D) Decrease in ABCG2 expression in Sox2 s
expression was evaluated by qRT-PCR and results are presented as bar diag5H, Src-kinase inhibitors dasatinib or PP2, as well as
PI3K/Akt inhibitor LY294002 showed a significant (5–7
fold; p < 0.001) decrease in sphere formation; MEK in-
hibition by PD98059 did not have any significant effect
on self-renewal. The average size of the spheres formed
was found to be 7–10 folds smaller than the untreated
cells. Collectively, these data indicated that inhibition of
EGFR/Src/Akt signaling results in depletion of Sox2 ex-
pression and decreased self-renewal of SP cells.
Suppression of Sox2 expression is sufficient to inhibit the
self-renewal of SP cells
Since inhibition of EGFR/Src/Akt signaling specifically
downregulated the expression of Sox2, we examined the
contribution of Sox2 to the self-renewal of H165SP-Adh
cells. Transient transfection of EGFR and Src siRNA in
H1650-SPadh cells reduced EGFR expression by 60%
and Src expression by 50%. Reduction in EGFR or Src
expression decreased the levels of Sox2 by 50% and 40%
respectively; the expression of Oct4 and Nanog was not
altered (Figure 6A). In addition, depletion of EGFR ors. (A) H1650-SPAdh cells were transfected with non-targeting control
rformed for Sox2, Oct4, EGFR and Src expression. (B) siRNA transfected
. Average number of spheres generated per well from 1000 cells is
Sox2 siRNAs and SP frequency was evaluated. Average fold change in
iRNA transfected cells was detected by western blotting. The Sox2
ram.
Singh et al. Molecular Cancer 2012, 11:73 Page 10 of 15
http://www.molecular-cancer.com/content/11/1/73Src by siRNA suppressed the sphere formation by 2–3
folds (Figure 6B). To further explore the function of
Sox2 in self-renewal of SP cells, we depleted Sox2 ex-
pression in H1650-SPadh cells. Transient transfection of
Sox2 siRNA reduced the expression of Sox2 by 60%
(Figure 6A). Depletion of Sox2 expression did not sig-
nificantly alter the expression of Oct4 or Nanog expres-
sion in H1650-SPadh cells (Figure 6AB), and reduced
the sphere formation by approximately 2.5 folds (Fig-
ure 6) with a corresponding reduction in the average size
(p = 0.003). Depletion of Sox2 expression resulted in a
pronounced decrease in the frequency of SP cells
(Figure 6C) as well as ABCG2 expression (Figure 6D) in
A549, H1650 and H1975 cells compared to control
siRNA transfected cells. Similar results were obtained
when a different siRNA to Sox2 was used (Additional
file 1: Figure S3). Collectively, these results suggest that
Sox2 gene has a direct role in maintaining cancer stem
cell characteristics and self-renewal of SP cells from
NSCLC.
Sox2 is expressed in NSCLC and is associated with
metastatic progression
Our data showing that depletion of Sox2 affects the self-
renewal properties of stem-like cells, we next examined
Sox2 expression in a panel of NSCLC tumor samples
obtained from stage I/II or stage IV patients on tissue
microarrays (TMAs) by immunohistochemistry. Samples
from 193 patients with NSCLC-stage I/II disease includ-
ing 73 with adenocarcinoma were on one TMA; samples
from 103 stage IV-NSCLC patients including 45 with
adenocarcinoma from primary site and 17 adenocarcin-
oma samples from the metastatic sites were on the sec-
ond TMA. In accordance with earlier reports, Sox2 was
strongly expressed in squamous cell carcinoma (SCC)
samples for both stage I/II and IV patients (Figure 7A (i
and ii)). In contrast to SCCs, adenocarcinoma samples
had significantly lower expression of Sox2. Sox2 positive
cells were heterogeneously distributed in adenocarcin-
oma samples for both stage I/II and IV patients
(Figure 7A (iii and iv). While there was no significant
difference in Sox2 expression between different grades
of tumors, elevated expression of Sox2 was positively
associated with metastatic progression. Representative
images for adenocarcinoma-metastases are shown in
Figure 7A (v-viii). Approximately 67% of stage I/II
(n = 73) and 73% of stage IV (primary site, n = 45)
tumors were detected as positive for Sox2 expression
(score ≥ 1) using a semi-quantitative scoring system.
Compared to the primary site tumor for stage IV
patients, higher numbers of metastasized tumors were
positive for Sox2 (Figure 7B). The median score for Sox2
expression is represented as histogram (Figure 7C). The
average score for Sox2 expression was found to besignificantly higher (p= 0.01) in metastasized tumors as
compared to the primary site or lower stage tumors.
Overall, Sox2 was expressed in all stages of adenocarcin-
oma and its levels were significantly higher in metastatic
lesions.
Discussion
In the current study, we used the SP phenotype to iden-
tify and enrich a subpopulation of NSCLCs with the
properties ascribed to CSCs. The studies presented here
demonstrates a specific and significant role for EGFR
signaling cascade in facilitating the self-renewal growth
and expansion of the side population cells from
NSCLCs.
Our study, in accordance with earlier studies [11],
[33], confirmed the presence of SP cells in established
human NSCLC cell lines and in human tumor xeno-
grafts with the properties of CSCs. Comparing the self-
renewal ability of SP and MP cells isolated from human
tumor xenografts, we found that approximately 0.2% SP
cells were able to self-renew and form spheres, whereas
MP cells were unable to self-renew. Comparing the per-
centage of sphere forming cells in SP cells, we estimate
that approximately 1-2% of SP cells from established cell
lines may have stem-like properties; therefore, SP pheno-
type may not be the exclusive marker for CSCs, but can
be used to enrich stem-like cells from NSCLCs.
SP cells were found to be more tumorigenic in vivo,
confirming the enrichment of tumor initiating cells in
SP compartment. These cells were able to produce
highly invasive disease upon implantation into the lungs.
Also, the direct association of stem-like cells with gener-
ation of metastatic disease may be supported by our ob-
servation where a significant correlation was observed
between high Sox2 expressions in the metastatic tumors
of lung adenocarcinoma patients. Recent reports indicate
that the normal epithelial cells acquire the CSCs proper-
ties upon induction of EMT governed by various cyto-
kines and growth factors from stromal cells [10,25]. Our
results demonstrate that SP-cells intrinsically exhibit loss
of epithelial markers and/or the gain of mesenchymal
markers as compared to MP cells and could be due to
the higher expression of transcription factors Twist, Slug
and Snail, which are known to be involved in maintain-
ing the mesenchymal phenotype. Together with the ex-
pression of embryonic stem cell transcription factors like
Oct4, Sox2, and Nanog along with the exhibition of
EMT like features and orthotopic tumor-forming ability,
collectively suggest that SP cells isolated from NSCLC
cell lines and tumors have stem-like properties. The ob-
servation that EGFR signaling affects stem-like functions
of SP cells is intriguing, given that several EGFR
tyrosine-kinase inhibitors have efficacy against NSCLCs
[34,35]. Interestingly, EGFR appears to regulate Sox2
Figure 7 Sox2 expression correlates with metastatic progression of adenocarcinoma. (A) Sox2 expression in Lung squamous cells
carcinoma, adenocarcinoma and metastatic adenocarcinoma was analyzed from stage I/II or stage IV patients samples by immunohistochemistry.
(B) Semi-quantitative scoring was performed for adenocarcinoma samples and the tumors with score of one or more was considered positive for
Sox2 expression and listed. (C) Median score for Sox2 expression was calculated and plotted for different stages of NSCLC progression. The mean
(± SD) of score is mentioned in parenthesis. Metastatic tumors showed significantly (p = 0.01) higher expression of Sox2.
Singh et al. Molecular Cancer 2012, 11:73 Page 11 of 15
http://www.molecular-cancer.com/content/11/1/73levels, through the Src-Akt pathway; Sox2 has been
shown to be regulated by Akt in ES cells, through the in-
hibition of proteasomal degradation [36]. Consistent
with these results, our observation suggest that inhib-
ition of EGFR-Src-Akt signaling downregulates Sox2
levels along with a reduction in ABCG2 levels. This de-
crease in ABCG2 expression upon EGFR inhibition is
probably a causal effect of Sox2 depletion-mediated dif-
ferentiation of SP into MP cells.
The fact that EGFR-pathway inhibition resulted in spe-
cific depletion of Sox2 without any significant effect on
Oct4 or Nanog expression suggests that their expression
may be regulated through independent mechanisms in
NSCLC SP cells. Our results as well as an earlier report
[37] suggest that Sox2 is expressed in both low as well
as high stage adenocarcinomas irrespective of their
grades. However, Oct4 or Nanog expression was found
to be associated only with the high grade lung adenocar-
cinoma and not expressed in low grade tumors [17,37].
Therefore, we predict that the EGFR pathway inhibition
may exert its favorable effects only for those tumors
where Sox2 is the major determinant in controlling the
self-renewal of CSCs. Interestingly, a recent studyshowed that the ectopic overexpression of Oct4 and
Nanog increases the tumor initiating property of A549
cells [17]. In agreement with these reports, we find that
specific and independent depletion of Oct4 or Nanog
also resulted in decrease in SP phenotype but in a cell
type dependent fashion (Data not shown). Two recent
reports demonstrate that ectopic expression of Sox2
increased the frequency of side population cells and
tumor formation in mouse and human NSCLC cell lines
[33,38]. These reports strongly suggest that Sox2 expres-
sing cells harbor the stem cell-like properties. Our ob-
servation further strengthens this postulation where we
demonstrate that Sox2 depletion was sufficient to inhibit
the self-renewing property SP cells in all the three
NSCLC cell lines.
In addition to the mutation in EGFR signaling, per-
turbation of p53 activity is another important event
occurs in initiation and progression of NSCLCs [39]. Re-
cently, p53 is shown to have certain roles in promoting
the differentiation of human embryonic stem cell
through repression of factors like Oct4, Klf4, Lin28A,
and Sox2 [40]. However, there is not much information
available on the direct role of p53 transcriptional
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in cancer, and would be interesting to explore in future.Conclusions
Figure 8 summarizes the role of Sox2 in SP cell biology
and tumor growth. While certain frequency of isolated
SP cells from NSCLC exhibit stem cell-like properties
and can form metastatic tumors, more differentiated MP
cells are greatly impaired in their ability to generate
tumors. Further, inhibition of EGFR pathway including
Src and PI3-kinase could strongly inhibit the expression
of Sox2, suppressing the self-renewal properties of SP
cells. Therefore, relative Sox2 expression and functions
within the tumor-CSCs may be a major determinant in
EGFR-targeted therapy against NSCLCs. This informa-
tion might also be potentially useful to overcome the
acquired resistance to EGFR therapies, by targeting
downstream targets of EGFR signaling, including Sox2.
Additional investigations in this direction might lead to
the development of more effective therapeutic agents to
combat NSCLC, especially those harboring EGFR
mutations.Materials and methods
Cell lines and tumor samples
H1650, and H1975 cell lines were obtained from
ATCC and maintained in RPMI or DMEM contain-
ing10% fetal bovine serum (FBS; Mediatech) in 5%
CO2 at 37°C. Human tumor xenografts were obtained
from SA laboratory.Figure 8 A schematic depiction of the signaling events that regulate
MP cells do not. Inhibiting EGFR, Src or PI3-kinase significantly impairs theInhibitors, siRNAs and antibodies
Gefitinib, Erlotinib, BIBW2992 and Dasatinib were pur-
chased from LC laboratories. PP2 and Fumitremorgin C
(FTC) were purchased from Sigma Inc. In the present
study, Gefitinib or erlotinib is used at 500 nM, dasatinib
or BIBW2992 is used at 200 nM and PP2 is used at
1 μM dose. siRNA against EGFR, Src family kinases, Akt
and Sox2, Oct4 and Nanog was purchased from Santa
Cruz Biotechnology or OriGene Technology Inc. Pri-
mary antibodies against Sox2 (#3579), Oct4 (#2750),
Nanog (#4903), Phos-Src-pY416 (#2101), pERK1/2
(#4376) and phospho-AKT-pS473 (#4058) were pur-
chased from Cell Signaling Technology; Phos-EGFR-
pY1068 (#44788G) from Invitrogen; EGFR neutralizing
antibody (#05-101) from Milipore and isotype matched
mouse IgG were purchased from Biolegend.
RNA preparation and qRT PCR analysis
RNA preparation and RT-PCR analysis was performed
as described earlier [41]. Fold inductions were calculated
using the formula 2–(ddCt) using GAPDH as internal con-
trol gene. The gene-specific primer pairs were as follows.
ABCG2 (F) 5’-CAC AAG GAA ACA CCA ATG GCT-3’,
ABCG2 (R) 5’-ACA GCT CCT TCA GTA AAT GCC
TTC-3’; Oct4 (F) 5’-ACA TCA AAG CTC TGC AGA
AAG AAC-3’, Oct4 (R) 5’-CTG AAT ACC TTC CCA
AAT AGA ACC C-3’, Sox2 (F) 5’-GGG AAA TGG GAG
GGG TGC AAA AGA-3’, Sox2 (R) 5’-TTG CGT GAG
TGT GGA TGG GAT TGG-3’, Nanog (F) 5’-AGA AGG
CCT CAG CAC CTA-3’, Nanog (R) 5’-GGC CTG ATT
GTT CCA GGA TT-3’; Twist (F) 5’-CTC GGA CAAthe biology of SP cells. Isolated SP cells form metastatic tumors but
self-renewal properties of SP cells.
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GAG CCA CAT AGC TGC AGC-3’, Slug (F) 5’- ACA
CAT TAC CTT GTG TTT GCA AGA TCT-3’, Slug (R)
5’- TGT CTG CAA ATG CTC TGT TGC AGT G-3’,
Snail (F) 5’- CCT CAA GAT GCA CAT CCG AAG
CCA C-3’, Snail (R) 5’- CCG GAC ATG GCC TTG TAG
CAG C-3’, GAPDH (F) 5’-GGT GGT CTC CTC TGA
CTT CAA CA-3’, GAPDH (R) 5’-GTT GCT GTA GCC
AAA TTC GTT GT-3’.Hoechst 33342 dye efflux assay for SP analysis and cell
sorting
Adherent cells were harvested using accutase reagent
(Sigma Inc). Human Tumor tissue grown in athymic
nude mice was minced, enzymatically digested with
0.2% collagenase IV (Worthington Biochemical Corpor-
ation) prepared in 10% FBS containing medium for
60 min at 37°C. The digest was further disaggregated
by passing through 10 ml pipette several times and fil-
tered through 100/70-μm cell strainer to obtain a sin-
gle cell suspension. Cells were washed and resuspended
in HBSS at 1X106 cells/ml density and incubated with
4 μg/ml of Hoechst 33342 dye (Invitrogen) for 90 min
at 370C in presence or absence of 1 μM FTC, as
described by Goodell et al. [21]. Cells were incubated
with 2 μg/ml Propidium iodide (PI; Sigma Inc) before
analysis to visualize and exclude the non-viable cells.
The Hoechst 33342 dye was excited at 350 nm using
UV laser and its fluorescence was analyzed using 400–
500 nm BP filter for blue emission and 640–680 nm
BP filter in combination with 655 nm LP-filter for red
emission. Flow cytometers from BD Biosciences were
used for data acquisition. Data were acquired using
LSRII or FACS Vantage (DiVa), and sorted using FACS
Vantage (DiVa) cell sorter. Data analyses were done
using FlowJo software (Tree Star). Cell cycle analyses
for fixed cells were performed for PI stained cells using
Vindelov method with similar protocol as described
earlier [41].Sphere formation or Self renewal assay
Sorted SP or MP cells were plated in 96 well plates at
the density of 10,000 cells/ml (1000 cells/well in 100 μl
medium) in serum free stem cell selective media
(DMEM/F12K (1:1) (Invitrogen), supplemented with 1X-
N2 supplement (Invitrogen), 10 ng/ml EGF and 10 ng/
ml bFGF (Sigma)) and allowed to grow as spheres for
10 days. Images of the spheres were taken using phase
contrast microscope (Nikon) and total numbers were
counted. To study the effect of drugs on the self-renewal
of SP cells, drugs were added to the respective wells on
day 1 and 5 and size and number of the spheres were
analyzed on day 10.Immunofluorescence
For immunostaining, spheres were transferred to poly
D-lysine/Laminin coated glass surface for 18 h. For
monolayer cultures, cells were directly plated over the
poly D-lysin/Laminin coated glass surface and cultured
or treated in stem cell selective media as indicated. Im-
munofluorescence staining was performed as described
previously [42]. Cells were observed using a Leica TCS
SP5 confocal microscope (Leica Microsystems) at × 630
magnification.
Immunohistochemistry
Human lung cancer tissue microarray (TMA) slides with
stage I/II or stage IV NSCLC patients were obtained
through Lung Cancer Specialized Program of Research
Excellence (SPORE). TMA slide with stage I/II tumor
samples contained usable cores from 193 patients, and
TMA slide with stage IV tumor samples contained usable
cores from 103 patients including 17 adenocarcinoma
samples from the metastatic sites. The Immunohisto-
chemical staining was performed as described [42]. The
samples were scored by a pathologist (D. Coppola). The
semiquantitative score was reached by taking into consid-
eration both cellularity and intensity of expression (semi-
quantitative score = cellularity × intensity). Cellularity was
scored as follows: a score of 3 equals to greater than 66%
cellularity, a score of 2 equals to 34%–65% cellularity, and
a score of 1 equals to less than 33% cellularity. Intensity
was scored as follows: a score of 3 equals to strong inten-
sity, a score of 2 equals to moderate intensity, and a score
of 1 equals to weak intensity [42]. The score of 1 or above
was considered as positive expression of Sox2. The images
were captured at × 200 magnification.
In vivo tumor formation assay and bioluminescence
imaging
5-weeks-old female SCID-beige mice were used for these
experiments under an IACUC approved protocol. For
orthotopic implantation of tumor cells, sorted SP or MP
cells from A549 cell line stably expressing luciferase
gene (A549-Luc) were washed with serum-free DMEM-
F12K medium and resuspended at indicated numbers in
HBSS containing 500 μg/ml growth factor reduced
Matrigel. Surgical procedure for orthotopic lung implant-
ation was followed as suggested earlier for intrapulmon-
ary implantation of tumor cells with some modifications
[43]. Specifically, cells were inoculated with 1 ml syringes
with 30-gauge hypodermic needles in an open technique
under direct visualization into the right lung tissue of
SCID mice anesthetized by gas anesthesia (3% isoflur-
ane). Tumor growth/metastases were imaged weekly
using bioluminescence by IVIS-200 imaging system from
Caliper Corporation. Mice were anesthetized and 30 mg/
Kg of D-luciferin in PBS was administered by
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tion, bioluminescence was imaged with a charge-coupled
device camera (Caliper) with an imaging time of 2 min.
At the end of the experiment, or when mice become
moribund, all of the mice were euthanized and individual
organs harvested for evaluation of tumor size; distant
metastases was determined by bioluminescence of luci-
ferase expressing cells.
Statistical methods
Data were presented as the mean ± standard deviation
(SD). To assess the statistical significance of differences,
student’s t test was performed. The data were consid-
ered statistically significant when the P value was less
than 0.05.
Additional file
Additional file 1: Figure S1. BIBW2992 inhibits EGFR phophorylation.
H1975 cells were treated with 500 nM gefitinib or 200 nM BIBW2992 for
5 days. EGFR phosphorylation and total EGFR expression was detected in
presence or absence of drug treatment. Figure S2. Downregulation of
Sox2 expression after EGFR and Src inhibition. H1650-SPAdh cells were
treated plated over PDL-Laminin coated glass surface and treated with
indicated drugs for 4 days. (A) Expression of Sox2 was monitored by
immunofluorescence confocal imaging. Isotype antibody was used to
show the specific staining of Sox2. (B) Number of Sox2 positive cells for
each treatment condition were converted into percentage and plotted. P
values were calculated from three different experiments and suggested a
significant decrease in Sox2 positive cells after EGFR and Src inhibition.
(C) Under similar treatm,ent conditions cells were stained with Nanog
specific antibodies. Drug treatment did not alter the expression of Nanog
in H1650-SPAdh cells. Figure S3. Depletion of Sox2 expression
suppresses SP frequency. (A) A549, H1650 and H1975 cells were
transiently transfected with second set siRNA (purchased from Origene).
48 h after transfection, cells were analyzed for SP frequency. Similar to
first set of siRNA (purchased from SantaCruz), depletion of Sox2 resulted
in significant decrease in SP frequency in NSCLCs. (B) NSCLC cells were
transfected with Sox2 SIRNA and ABCG2 expression was detected by
western blotting. β-Actin was used as internal control for equal loading. *
p<0.05.
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